Cargando…
Cell-Based Regeneration and Treatment of Liver Diseases
The liver, in combination with a functional biliary system, is responsible for maintaining a great number of vital body functions. However, acute and chronic liver diseases may lead to irreversible liver damage and, ultimately, liver failure. At the moment, the best curative option for patients suff...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508969/ https://www.ncbi.nlm.nih.gov/pubmed/34638617 http://dx.doi.org/10.3390/ijms221910276 |
_version_ | 1784582223699116032 |
---|---|
author | Hofmann, Julia Hackl, Verena Esser, Hannah Meszaros, Andras T. Fodor, Margot Öfner, Dietmar Troppmair, Jakob Schneeberger, Stefan Hautz, Theresa |
author_facet | Hofmann, Julia Hackl, Verena Esser, Hannah Meszaros, Andras T. Fodor, Margot Öfner, Dietmar Troppmair, Jakob Schneeberger, Stefan Hautz, Theresa |
author_sort | Hofmann, Julia |
collection | PubMed |
description | The liver, in combination with a functional biliary system, is responsible for maintaining a great number of vital body functions. However, acute and chronic liver diseases may lead to irreversible liver damage and, ultimately, liver failure. At the moment, the best curative option for patients suffering from end-stage liver disease is liver transplantation. However, the number of donor livers required by far surpasses the supply, leading to a significant organ shortage. Cellular therapies play an increasing role in the restoration of organ function and can be integrated into organ transplantation protocols. Different types and sources of stem cells are considered for this purpose, but highly specific immune cells are also the focus of attention when developing individualized therapies. In-depth knowledge of the underlying mechanisms governing cell differentiation and engraftment is crucial for clinical implementation. Additionally, novel technologies such as ex vivo machine perfusion and recent developments in tissue engineering may hold promising potential for the implementation of cell-based therapies to restore proper organ function. |
format | Online Article Text |
id | pubmed-8508969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85089692021-10-13 Cell-Based Regeneration and Treatment of Liver Diseases Hofmann, Julia Hackl, Verena Esser, Hannah Meszaros, Andras T. Fodor, Margot Öfner, Dietmar Troppmair, Jakob Schneeberger, Stefan Hautz, Theresa Int J Mol Sci Review The liver, in combination with a functional biliary system, is responsible for maintaining a great number of vital body functions. However, acute and chronic liver diseases may lead to irreversible liver damage and, ultimately, liver failure. At the moment, the best curative option for patients suffering from end-stage liver disease is liver transplantation. However, the number of donor livers required by far surpasses the supply, leading to a significant organ shortage. Cellular therapies play an increasing role in the restoration of organ function and can be integrated into organ transplantation protocols. Different types and sources of stem cells are considered for this purpose, but highly specific immune cells are also the focus of attention when developing individualized therapies. In-depth knowledge of the underlying mechanisms governing cell differentiation and engraftment is crucial for clinical implementation. Additionally, novel technologies such as ex vivo machine perfusion and recent developments in tissue engineering may hold promising potential for the implementation of cell-based therapies to restore proper organ function. MDPI 2021-09-24 /pmc/articles/PMC8508969/ /pubmed/34638617 http://dx.doi.org/10.3390/ijms221910276 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hofmann, Julia Hackl, Verena Esser, Hannah Meszaros, Andras T. Fodor, Margot Öfner, Dietmar Troppmair, Jakob Schneeberger, Stefan Hautz, Theresa Cell-Based Regeneration and Treatment of Liver Diseases |
title | Cell-Based Regeneration and Treatment of Liver Diseases |
title_full | Cell-Based Regeneration and Treatment of Liver Diseases |
title_fullStr | Cell-Based Regeneration and Treatment of Liver Diseases |
title_full_unstemmed | Cell-Based Regeneration and Treatment of Liver Diseases |
title_short | Cell-Based Regeneration and Treatment of Liver Diseases |
title_sort | cell-based regeneration and treatment of liver diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508969/ https://www.ncbi.nlm.nih.gov/pubmed/34638617 http://dx.doi.org/10.3390/ijms221910276 |
work_keys_str_mv | AT hofmannjulia cellbasedregenerationandtreatmentofliverdiseases AT hacklverena cellbasedregenerationandtreatmentofliverdiseases AT esserhannah cellbasedregenerationandtreatmentofliverdiseases AT meszarosandrast cellbasedregenerationandtreatmentofliverdiseases AT fodormargot cellbasedregenerationandtreatmentofliverdiseases AT ofnerdietmar cellbasedregenerationandtreatmentofliverdiseases AT troppmairjakob cellbasedregenerationandtreatmentofliverdiseases AT schneebergerstefan cellbasedregenerationandtreatmentofliverdiseases AT hautztheresa cellbasedregenerationandtreatmentofliverdiseases |